EMVIA
"EMVIA" is a trademark owned by Embecta Corp., filed at the WIPO on September 4, 2023. It is on file and covers classes 5, 9, 10 and 42.
- Status
- Mixed
- Filed
- September 4, 2023
- Registered
- Not yet
- Expires
- September 4, 2033
- Application no.
- Not recorded
- Registration no.
- 1773590
- Office
- WIPO
- World Intellectual Property Organization
- Mark type
- Trademark
- 4 classes
Who owns EMVIA
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Embecta Corp.
EMBC · United States
Representative
Meisser & Partners AG
Meisser & Partners AG
What the mark covers
The products and services EMVIA is filed for, grouped by Nice class.
Reagents for medical use; diagnostic test reagents for medical purposes; medical diagnostic reagents for testing and analyzing body fluids; diagnostic reagents for measuring blood ketone levels for medical use; diagnostic reagents for immunization for medical use; diagnostic agents for medical use; enzyme preparations for medical purposes; in vitro diagnostic reagents for medical purposes; test strips and control solutions for testing blood glucose levels; medical diagnostic test strips and control solutions for blood analysis; cotton for medical purposes; test strips for the detection of blood glucose.
Downloadable computer software and hardware for use in the acquisition, capture, processing, presentation, storage, and transmission of medical and physiological data; Downloadable computer software for use by one or more individuals to acquire, receive, store, process, analyze, access, present, report, and/or transmit medical and physiological data; downloadable computer software for monitoring blood glucose in connection with blood glucose monitors; downloadable software in the nature of a mobile application for monitoring blood glucose in connection with blood glucose monitors.
Blood testing apparatus for medical use; Analysers for analysing and measuring the level of glucose in the blood for medical use; blood glucose meters; devices for measuring blood sugar levels for medical purposes; medical diagnostic apparatus and instruments for testing blood sugar levels; medical apparatus for testing the level of glucose in the blood; in vitro diagnostic devices for medical purposes, namely, for blood analysis; blood analysis apparatus for medical diagnostic purposes; monitors, medical apparatus and instruments for continuous blood glucose monitoring; blood gas monitoring systems comprised of monitors, medical instruments for monitoring blood coagulation, electrodes for medical use; glycated haemoglobin measuring apparatus for medical purposes; sensor apparatus for medical use in diagnosis, namely, blood glucose sensors; sensors for continuous blood glucose monitor for monitoring blood glucose for medical purposes; apparatus for taking blood, namely, lancets, lancing devices and other finger-pricking devices used to draw blood to be used with blood glucose monitoring devices or for other medical uses for medical purposes; mobile monitoring scanners for medical purposes, namely, ultrasound imaging scanners; medical devices, namely, medical sensors that are implanted or inserted into the human body used to continuously monitor the concentration of glucose in the human body and accessories therefor, namely, receivers, sensor housings and sensor insertion devices; continuous glucose monitoring systems composed of medical apparatus for monitoring glucose; medical apparatus and instruments for monitoring interstitial fluid glucose; sensor-based glucose monitors for medical purposes; continuous glucose monitoring systems primarily composed of medical apparatus for monitoring interstitial fluid glucose.
Providing temporary use of non-downloadable cloud-based software for use in the acquisition, capture, processing, presentation, storage, and transmission of medical and physiological data; Providing temporary use of non-downloadable cloud-based software for use by one or more individuals to acquire, receive, store, process, analyze, access, present, report, and/or transmit medical and physiological data; providing temporary use of non-downloadable cloud-based software for monitoring blood glucose in connection with blood glucose monitors.
About EMVIA
Who owns the trademark "EMVIA"?
The WIPO trademark "EMVIA" is owned by Embecta Corp.
What is the status of "EMVIA"?
Its status at the WIPO is: mixed.
Get this data via the API
Everything on this page comes from the Signa API. Pull EMVIA and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_1bfbdfc9-5935-4f55-97b7-dea72752181e
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_1bfbdfc9-5935-4f55-97b7-dea72752181e",
"object": "trademark",
"mark_text": "EMVIA",
"status": {
"primary": "mixed",
"stage": "mixed"
},
"office_code": "WO",
"application_number": null,
"filing_date": "2023-09-04",
"nice_classes": [
5,
9,
10,
42
],
"owners": [
{
"name": "EMBECTA CORP.",
"entity_id": "ent_019eb725-f8a2-738c-a497-7ff511f9a095"
}
]
}